Vaccine and Immunology

Immunotherapy in Cancer Treatment

Immunotherapy has revolutionized cancer treatment by harnessing the immune system to target and eliminate tumor cells. Strategies include immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, cancer vaccines, and monoclonal antibodies. These approaches enhance the body’s natural immune surveillance, overcoming tumor-mediated immune evasion. Personalized immunotherapy, guided by genetic, epigenetic, and proteomic profiling, allows for targeted interventions tailored to the patient’s tumor biology. Clinical trials are increasingly combining immunotherapy with chemotherapy, radiotherapy, or targeted agents to enhance efficacy. Advances in nanotechnology and delivery systems optimize immune activation while minimizing toxicity. Biomarker discovery and immune monitoring facilitate patient stratification, response assessment, and early detection of adverse events. Integrating immunotherapy into standard oncology practice requires multidisciplinary collaboration, regulatory oversight, and equitable access to cutting-edge treatments.